The FDA has issued a provisional approval for cannabis extracts to treat nausea and vomiting associated with chemotherapy.
The approval was issued on July 10 and will be available to medical marijuana dispensaries starting August 17.
The FDA also approved a CBD-rich cannabis oil for treatment of Crohn’s disease and Crohn-related disorders.CBD is a non-psychoactive component of cannabis that has been found to be safe, effective, and has no harmful side effects, according to the FDA.
The cannabis extract is being made by Cannavar and it has been shown to treat Crohn disease and other symptoms associated with Crohn, according the company.
The oil is being developed by Canna-Rad, a cannabis company based in Colorado, and the FDA has not issued a final decision on whether to approve it.
The FDA is reviewing all medical marijuana applications to determine whether the CBD oil will meet its requirements, the agency said in a press release.
“This review will focus on CBD’s effects on nausea and the treatment of nausea associated with various conditions,” the agency added.